Prof. Abid Jameel

Prof. Abid Jameel

Professor Department of Oncology

MBBS, FCPS
Dept: Oncology
BPS: 20

Research & Publications

  1. 1.   Jameel A, Noor SM, Ayub S, Ali SS, Park YS, Tekian A. Feasibility, relevance and effectiveness of teaching and assessment of ethical status and communication skills as attributes of professionalism. J Pak Med Assoc. 65 (7): 721-6; 2015. (IF = 0.4)
  2. 2.   Iqbal Z, Akhtar T, Awan T, Aleem A, Sabir N, Absar M, Shammas MA, Ijaz H Shah, Khalid M, Taj, AS, Jameel A, Alanazi A et al. High frequency and poor prognosis of late childhood BCR-ABL positive and MLL-AF4 positive ALL define the need for advanced molecular diagnostics and improved therapeutic strategies in Paediatric B-ALL in Pakistan. Molecular Diagnosis and Therapy· June 2015. (IF 2.59)
  3. 3.   Rawlings A, Knox ADC, Park, YS, Reddy S, Williams SR, Issa N, Jameel A, Tekian A. P. Development and Evaluation of Standardized Narrative Cases Depicting the General Surgery Professionalism Milestones. Acad Med. E-pub ahead of print - Online doi: 10.1097/ACM.0739; Apr 2015. (IF = 3.47)
  4. 4.   Jameel A, Noor SM, Ayub S, Tekian A. Why is teaching professionalism essential in residency programs? Med Educ. 47 (5): 531-2, 2013. (IF = 3.62)
  5. 5.   Iqbal Z1, Aleem A, Iqbal M, Naqvi MI, Gill A, Taj AS, Qayyum A, ur-Rehman N, Khalid AM, Shah IH, Khalid M, Haq R, Khan M, Baig SM, Jamil A, Abbas MN, Absar M, Mahmood A, Rasool M, Akhtar T. Sensitive detection of pre-existing BCR-ABL kinase domain mutations in CD34+ cells of newly diagnosed chronic-phase chronic myeloid leukemia patients is associated with imatinib resistance: implications in the post-imatinib era. PLoS One. 2013;8(2):e55717. doi: 10.1371/journal.pone.0055717. Epub 2013 Feb 8. (IF = 3.53)
  6. 6.   Jameel A, Chiragh S, Farooq M, Iqbal S. Clinico-pathological presentation and therapeutic options for hairy cell leukemia. J. Postgrad Med Inst. 26 (3): 336-9, 2012.
  7. 7.   Jameel A, Noor SM, Ayub S. Survey on perceptions and skills amongst postgraduate residents regarding breaking bad news at teaching hospitals in Peshawar, Pakistan. J Pak Med Assoc. 62 (6): 585-9, 2012. (IF = 0.4)
  8. 8.   Jameel A. Case Report - Philadelphia chromosome positive acute myeloid leukemia: a rare hematological disorder. J. Postgrad Med Inst. 26 (1): 111-4, 2012.
  9. 9.   Jameel A, Farooq M, Ullah S. Breaking Bad News – Perceptions of cancer patients and their relatives. J Postgrad Med Inst. 25 (4): 304-8, 2011.
  10. 10.   Jameel A and Jamil SN. Management of cancer during pregnancy. J Postgrad Med Inst. 22 (1): 3-7, 2008.
  11. 11.   Shaharyar, Hafeez M, Masood AI, Perveen S, Murad S, Randhawa I, Rasool S, Shah IH, Jamil A et al. Rationale of sequential AC-Docetaxel Neoadjuvant chemotherapy followed by modified radical mastectomy and post-operative radiation to chest wall and peripheral lymphatics in locally advanced breast cancer. Biomedica 23; 54-6, 2007.
  12. 12.   Hafeez M, Shaharyar, Javed AA, Jamil A, Shah IH, Shahid A, Perveen S, Masood AI, Shabbir K, Rasool S. Rationale of laryngeal conservation with induction chemotherapy followed by concomitant chemo radiotherapy in resectable stage III and IV cancer of larynx and hypopharynx. Pak J Med Health Sci 1 (2): 52-3, 2007.
  13. 13.   Shaharyar, Shah IH, Javed AA, Jamil A, Shahid A, Hafeez M, Perveen S, Masood AI, Shabbir K, Rasool S. Stage III A & B non-small cell lung cancer: Rationale of concomitant chemo-radiotherapy followed by consolidation chemotherapy and prophylactic cranial irradiation. Professional Med J 14 (1): 181-6, 2007.
  14. 14.   Jameel A and Jamil S. Incidence of deep vein thrombosis in cancer patients in northern Pakistan. J Med Sci 15 (1): 44-8, 2007.
  15. 15.   Jameel A. Glanzmann's thrombasthenia: Presentation and management of a rare bleeding disorder. J Coll Physicians Surg Pak. 17 (4): 246-7, 2007. (IF = 0.32)
  16. 16.   Jameel A and Jamil S N. Safety of cytotoxic chemotherapy during pregnancy. J Pak Med Assoc. 57 (9): 449-52, 2007. (IF = 0.4)
  17. 17.   Jameel A and Jamil S. Malignant Pleural Mesothelioma in Northern Pakistan and its response to treatment. Pak J Med Res, 45 (2): 59-62, 2006. (IF = 0.1)
  18. 18.   Shaharyar, Shahid A, Shah IH, Javed AA, Jamil A et al. Rationale of three weekly schedule of intravenous irinotecan, leucovorin and 5-fluorouracil in unresectable, locally advanced, recurrent or metastatic colorectal carcinoma. Ann King Edward Med Coll, 12 (3): 461-3, 2006
  19. 19.   Shaharyar, Jamil A, Shah IH et al. Rationale of concurrent Docetaxel chemotherapy and radiation to chest wall & peripheral lymphatics after four cycles of AC chemotherapy in patients with early breast cancer. Ann King Edward Med Coll, 12 (4): 588-90, 2006.
  20. 20.   Jameel A and Jamil SN. Clinico-Pathological profile of Chronic Myeloid Leukemia. J Postgrad Med Inst., 20 (3): 235-8, 2006.
  21. 21.   Jameel A. Plasma cell leukaemia: Case report of a rare and aggressive variant of multiple myeloma. J Pak Med Assoc, 55 (10): 452-3, 2005. (IF = 0.4)
  22. 22.   Khan P, Jameel A, and Zaidi A. Role of Pamidronate disodium in reducing skeletal related events in patients with metastatic bone disease: A pilot study. J Postgrad Med Inst, 13 (2): 78-81, 1999.
  23. 23.   Jameel A, Khan J and Khan M.A. Remission and survival rates of acute myeloid leukemia in Peshawar. Pak J. Med. Res, 37 (1): 30-3, 1998.
  24. 24.   Jameel A, Khan P and Khan M.A. Comparison between combinations of tropisetron and dexamethasone with metoclopramide cocktail in the prevention of cisplatin-induced nausea and vomiting. Pak J. Med. Res, 36 (4): 164-8, 1997.
  25. 25.   Khan J, Khan P and Jameel A. Retaliation of Salmonella. J. Postgrad. Med. Inst, 10 (1): 53-8, 1996.
  26. 26.   Jameel A, Iqbal T, Khan . and Khan M.A. Diagnosis of undifferentiated carcinoma with the help of monoclonal antibodies. J. Postgrad. Med. Inst, 10 (1): 110-3, 1996.
  27. 27.   Jameel A, Khan P and Khan M.A. Endocrine treatment of breast cancer- a review. J. Postgrad. Med. Inst, 10 (2): 121-9, 1996.
  28. 28.   Jameel A, Stein R.C, Rawson N.S.B, Hedley A, Stuttaford J and Coombes R.C. Comparative study of intramuscular ketorolac tromethamine and morphine in patients experiencing cancer pain. Int. J. Oncology, 6: 1307-11, 1995. (IF = 2.77)
  29. 29.   Jameel A, Law M, Coombes R.C and Luqmani Y.A. Significance of heat shock protein 90 as a prognostic indicator in breast cancer. Int. J. Oncology, 2 (6): 1075-80, 1993. (IF = 2.77)
  30. 30.   Jameel A, Skilton R.A, Campbell T.A, Chander S.K, Coombes R.C and Luqmani Y.A. Clinical and biological significance of HSP 89 alpha in human breast cancer. Int. J. Cancer, 50: 409-15, 1992. (IF = 5.01).
  31. 31.   Luqmani Y.A, Skilton R, Campbell T, Jameel A and Coombes R.C. Differential hybridization and immunoscreening of expression libraries in an attempt to identify breast cancer associated molecules. Fibrinolysis, 6 (Suppl 4): 161-9, 1992.
  32. 32.   March 2017: Organized and Facilitated One Day Symposium on “Colorectal Carcinoma” on 26th March 2017 at Gomal Medical College, Dera Ismail Khan
  33. 33.   April 2017: Facilitation of Workshop at 5th International Conference on HPER: “Providing Constructive Feedback For Better Outcome” at Khyber Medical University, Peshawar on 07th April 2017
  34. 34.   April 2017: Facilitation of Workshop at 5th International Conference on HPER: “Providing Constructive Feedback For Better Outcome” at Khyber Medical University, Peshawar on 07th April 2017
  35. 35.   April 2017: Organized and Facilitated One Day CME Workshop on “Medical Errors” on 24th April 2017 at PGMI, Peshawar
  36. 36.   May 2017: Organized and Facilitated in Two-Day Workshop on “Developing Leaders For Tomorrow” on 23rd and 24th May 2017 at PGMI, Peshawar
  37. 37.   May 2017: Facilitation of One Day Workshop on “Professionalism and Social Media Accountability” on 18th May 2017 at LRH, Peshawar
  38. 38.   August 2017: Organized and Facilitated in One Day Workshop on CML Management at Gilgit on 01 August 2017.
  39. 39.   October 2017: Organized a one-day seminar on Project Management – Maximizing Professional Potential at PC Bhurban on 21st October 2017.
  40. 40.   November 2017: Organized and Facilitated in One Day Symposia on “Management of CML – A Comprehensive Review” at PC Hotel, Peshawar on 25th November 2017.
  41. 41.   February 2018: Organized and Facilitated One Day Symposium on “Renal Cell Carcinoma and Social Media Ethics” at Khalifa Gul Nawaz Teaching Hospital Bannu on 16th February 2018
  42. 42.   February 2018: Organized and Facilitated One Day Symposium on “Renal Cell Carcinoma and Social Media Ethics” at Gomal Medical College, Dera Ismail Khan on 17th February 2018
  43. 43.   March 2018: Organized and Facilitated Two Day Workshop on “Professionalism and Medical Ethics” at PGMI, Peshawar on 13th and 14th March 2018
  44. 44.   May 2018: Organized and Facilitated a One Day Symposium on “Renal Cell Carcinoma” on 11th May 2018 at Saidu Medical College, Swat.
  45. 45.   May 2018: Facilitation of One-Day Workshop on “Professionalism” at Saidu Medical College, Swat on 12th May 2018.
  46. 46.   August 2018: Facilitation of Two Day Workshop on “Professionalism Medial Ethics”: at PGMI Peshawar on 28th and 29th August 2018.
  47. 47.   January 2019: Facilitated in CHPE Course “Professionalism Theme in Curriculum” at KMU, Peshawar on 24th January 2019
  48. 48.   March 2019: Organized and Facilitated Workshop on “Medical Research Day I and II” at PGMI Peshawar in March 2019.
  49. 49.   April 2019: Facilitation at CHPE Course at Peshawar Medical College on “Professionalism – Perspective of a Medical Teacher” on 02 April 2019.
  50. 50.   April 2109: Facilitated in MHPE Course “Medical Professionalism” at KMU, Peshawar on 27th April 2019.
  51. 51.   April 2019: Facilitation at CHPE Course at Peshawar Medical College on “Workplace Based Assessment: An Introduction” on 30th April 2019.
  52. 52.   June 2019: SYMPOSIUM - An Update on “Management of Breast Cancer and Myeloproliferative Disorders” at PC Peshawar: 19th June 2019
  53. 53.   30th July 2019: Organized and Facilitated a One Day CME Workshop on “Medical Errors” on 30th July 2019 at LRH, Peshawar.